Predicting pathologic ≥N2 disease in women with breast cancer
Abstract The distinction between pN1 and ≥pN2 breast cancer impacts treatment decisions. Using data from a single institution on women with cN0 invasive breast cancer who were treated with upfront surgery, had 1-3 positive SLNs, and underwent completion ALND, we used gradient boosted trees (XGBoost)...
Saved in:
| Main Authors: | Kerollos Nashat Wanis, Wenli Dong, Yu Shen, Funda Meric-Bernstam, Taiwo Adesoye, Henry M. Kuerer, Abigail S. Caudle, Nina Tamirisa, Sarah M. DeSnyder, Susie X. Sun, Isabelle Bedrosian, Puneet Singh, Solange E. Cox, Kelly K. Hunt, Rosa F. Hwang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | npj Breast Cancer |
| Online Access: | https://doi.org/10.1038/s41523-025-00757-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sequence of therapy impact on older women with comorbidities and triple-negative or HER2-positive breast cancer
by: Nina Tamirisa, et al.
Published: (2025-02-01) -
Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer
by: Nisreen Elsayegh, et al.
Published: (2018-06-01) -
Strategies for improving the management of immune-related adverse events
by: James L Gulley, et al.
Published: (2020-10-01) -
Estimation of polycyclic aromatic hydrocarbons (PAHs) emission and its toxicity potentials from the combustion of selected fuelwoods
by: Ebenezer Leke Odekanle, et al.
Published: (2024-12-01) -
Polymer-based nanoparticles for cancer theranostics: advances, challenges, and future perspectives
by: Kaylin Shanahan, et al.
Published: (2025-07-01)